Interop's New York IT Conference is scheduled for September 17-19 in New York City. Interop promises to help attendees build a lean, agile IT organization that can respond to today's rapidly changing business environment.
The Food and Drug Administration has posted a list of drugs that are being evaluated for potential safety issues online. The agency listed 20 drugs that were found to potentially cause serious adverse reactions such as cardiac arrest, overdose due to labeling or packaging confusion, and cancer.
A new issue brief from the National Association of State Chief Information Officers is urging CIOs to get involved with the Medicaid systems upgrades happening in their states. The brief, "The MITA Touch: State CIOs and Medicaid IT Transformation," describes the Medicaid Information Technology Architecture being developed by the federal Centers for Medicare and Medicaid Services. MITA is not merely a technical architecture, but also entails standardizing information and streamlining business processe, according to the brief. "State CIOs must understand that this can be a daunting task and will require considerable collaboration between state agencies and vendors, and a substantial modernization of current IT systems and also business practices and processes," the brief states.
In 2001, North Dakota lawmakers passed legislation that opened the door for a "telepharmacy" project after dozens of rural pharmacies went out of business. The project began with 10 volunteer sites in 2002 and has grown to 67 locations. The idea now may be catching on in other places, as other states have changed laws to allow for remote pharmacies. Alaska, Idaho, Illinois, Montana, South Dakota, Texas, Utah, Vermont, and Wyoming have all done so, and more are on the way.
Big technology companies are seeing their customers in the financial services sector pull back on existing and new Information Technology projects, according to recent data issued by Forrester Research. Forrester polled almost 950 high-ranking technology managers at large businesses in North America and Europe, and found that more than 40% of the companies have cut back their technology spending. More businesses in the United States have cut their spending than anywhere else, and financial services firms have been the most aggressive in trimming their technology purchases, according to the findings.
While I've been quiet lately on the subject of trade groups attempting to launch medical tourism accreditation programs, others have advanced the story.
First, Avery Comarow, of U.S. News & World Report, blogged about the Medical Tourism Association's bid to become an accrediting body.
Comarow reports that Karen Timmons, president and CEO of the Joint Commission International, resigned from the MTA's board of advisors "after the program was announced and featured on the MTA Web page." An advisory board to the trade group told the MTA's president that the association cannot accredit, according to Comarow, so the MTA swapped out "accreditation" for "certification" on its Web site.
After talking with Renee-Marie Stephano, chief operating officer of the MTA, back in July, I had anticipated that more information about the program would be on the association's Web site by now, but only promotional copy can be found at the time I'm writing this story. On the U.S. News blog, a comment attributed to Stephano states in part: "The media seeks comments from people in the 'quality' sector of healthcare to create controversy where there is none. MTA certification is not about the quality of medical services as clearly stated from the beginning."
I'm sure some might consider me biased on the subject, but I wouldn't go so far as to pin the confusion about this program—whether it's called accreditation or certification—on members of the media. As a business-to-business writer, I find that readers in the healthcare industry are much more grateful when we can provide them with useful, concise, and clear information than when we rile them. To that point, I remain interested to see the association's certification standards spelled out in a way that removes all doubt about its benefits and intent.
The International Medical Travel Association has also responded recently with written comments on the topic of international accreditation. In the IMTA's view, "it is neither sufficient nor professionally acceptable for an organization to simply declare itself a grantor of accreditation while lacking the requisite infrastructure and oversight."
The IMTA paper points out four common-sense guidelines for determining whether an organization is a legitimate accreditation agency. "We believe that with patient safety at stake, accreditation standards and processes must be vetted by internationally recognized accreditation organizations and government agencies," Steven Tucker, MD, president of the IMTA says in a prepared statement. "The emergence of trade groups and others declaring themselves as quality accreditors or certification authorities not only threatens the integrity of existing organizations, but also creates market confusion at a time when global outsourcing of medical care is a growing phenomenon."
Note: You can sign up to receive HealthLeaders Media Global, a free weekly e-newsletter that provides strategic information on the business of healthcare management from around the globe.